Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Lisinopril epimer

● In Stock

Catalogue No.:	VE009468
CAS No.:	N/A
Mol. Formula:	C21H31N3O5
Mol. Weight:	405.5 g/mol

Request a quote

Add to RFQ list

Additional information on Lisinopril epimer

Parent drug

Lisinopril

IUPAC Name

(R)-1-(L-Lysyl)-2-((R)-1-carboxy-3-phenylpropyl)pyrrolidine-2-carboxylic Acid

Pharmacopeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C([C@@]1([C@H](C(O)=O)CCC2=CC=CC=C2)N(C([C@H](CCCCN)N)=O)CCC1)O

Inchl

InChI=1S/C21H31N3O5/c22-13-5-4-9-17(23)18(25)24-14-6-12-21(24,20(28)29)16(19(26)27)11-10-15-7-2-1-3-8-15/h1-3,7-8,16-17H,4-6,9-14,22-23H2,(H,26,27)(H,28,29)/t16-,17-,21+/m0/s1InChI=1S/C21H31N3O5/c22-13-5-4-9-17(23)18(25)24-14-6-12-21(24,20(28)29)16(19(26)27)11-10-15-7-2-1-3-8-15/h1-3,7-8,16-17H,4-6,9-14,22-23H2,(H,26,27)(H,28,29)/t16-,17-,21+/m0/s1

Description

The compound Lisinopril epimer is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Lisinopril production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.